EDAP TMS reported EUR-9.08M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AngioDynamics USD -6.35M 4.55M Sep/2025
Boston Scientific USD 907M 434M Jun/2026
EDAP TMS EUR -9.08M 4.07M Mar/2026
Henry Schein USD 94M 13M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Veracyte USD 25.49M 3.22M Jun/2026